425: Strive CEO Updates on Semler Scientific Merger

Strive's CEO reposted a communication on X.com regarding the proposed business combination with Semler Scientific, emphasizing forward-looking statements and regulatory filing requirements.

Summary

• A communication was reposted by Matthew Cole, Chief Executive Officer of Strive, Inc., on X.com on October 10, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with such projections.
• Forward-looking statements cover the outlook and expectations for the proposed transaction, anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses.
• Details are provided on where to find additional information, including the upcoming Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders are urged to thoroughly read all relevant SEC filings before making any voting or investment decisions.
• Strive, Semler Scientific, and certain of their respective directors and executive officers may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a procedural update for a proposed merger, heavily focused on cautionary statements and risks associated with forward-looking information. It does not present new positive or negative financial results, leading to a neutral sentiment, albeit with a strong emphasis on potential challenges.

Positives

• The proposed business combination between Strive and Semler Scientific is expected to yield strategic and financial benefits.
• Anticipated cost savings and strategic gains are potential outcomes of the proposed transaction.

Negatives

• The proposed transaction may not close when expected or at all due to unfulfilled conditions.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction could cause dilution.
• Potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, also could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The proposed transaction is expected to yield strategic and financial benefits, including anticipated cost savings and strategic gains. The combined company anticipates future financial performance improvements and successful integration of businesses. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted this communication on X.com.

Industry Context

This communication is a standard procedural update related to a proposed merger, common in industries undergoing consolidation or strategic shifts. The mention of 'Bitcoin treasury strategies' suggests a potential innovative or non-traditional financial approach for the combined entity, which could differentiate it within its sector, though specific industry details are not provided in this filing.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in the section entitled 'TRANSACTIONS WITH RELATED PERSONS' included in Semler Scientific's definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive may experience dilution caused by the issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Customers of Strive and Semler Scientific may have potential adverse reactions to the proposed transaction.
• Business and employee relationships at both companies could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Recommendation

This filing is a procedural update regarding a proposed business combination, primarily serving as a cautionary statement about forward-looking information and detailing regulatory steps. It does not provide new financial results or strategic shifts that would warrant a strong buy or sell recommendation. Investors should hold their positions and await the comprehensive details in the full S-4 filing, which will include merger terms, financial projections, and the combined entity's strategy, before making significant investment decisions. The extensive list of risks highlights the inherent uncertainties of such transactions.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Investment, Bitcoin Treasury Strategy